FDA Approves New Implantable Device to Treat Pain From Diabetic Nerve Damage
Frontiers | Spinal Cord Stimulation as Treatment for Cancer and Chemotherapy-Induced Pain
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain - Sep 26, 2019
FDA approves Abbott spinal cord stimulation devices for back pain